Contents - Medicinski Fakultet u Sarajevu - University of Sarajevo

Folia Medica 2011; 46 No 1:28-34Table 1. Gender distribution of patients by histopathologic type of cancerHISTOLOGICALTYPE OFCANCERTotal patientsMALESEXFEMALENumber Percent Number Percent Number PercentAdenocarcinoma 105 43.8 85 35.6 20 8.4Squamous cellcarcinoma89 37.2 62 25.9 27 11.3Large cell carcinoma 3 1.5 2 0.8 1 0.4Micro cell carcinoma 42 17.5 34 14.2 8 3.4Total 239 100.0 183 76.5 56 23.5Table 2. Distribution of patients with NSCLC according to the TNM classificationHISTOPATHOLOGICALTYPE OF CANCERTotalpatientsTNM CLASSIFICATIONIIA IIB IIIA IIIB IVNum. Perc. Num. Perc. Num. Perc. Num. Perc. Num. Perc. Num. Perc.Adenocarcinoma 105 100.0 6 5.7 14 13.3 34 32.4 14 13.3 37 35.3Squamous cell carcinoma 89 100.0 3 3.3 6 6.7 40 44.9 21 23.7 19 21.4Large cell carcinoma 3 100.0 0 0.0 0 0.0 1 33.3 1 33.3 1 33.3Total 197 100.0 9 4.6 20 10.1 75 38.0 36 18.4 57 28.9The distribution of SCLC patients accordingto TNM classification is shown onTable 3. In the extended stage of lung cancerwere more affected (55.0%) compared to thelimited stage (45.0%).Table 3. Distribution of micro cell carcinomapatients according to tnm classificationHistopathological typeof cancer according toTNM classificationNumber ofpatientsPercentageLIMITED 20 45.0EXTENDED 22 55.0TOTAL 42 100.0Statistical analysis, shown on Figure 1,ANOVA test, demonstrated that there is statisticallysignificant differences mean valuesof platelets count between lung cancer patientsand control group at the level of significanceof p